Rapid7, Inc. provides cybersecurity software and services under the Rapid7, Nexpose, and Metasploit brand names. The company offers Rapid7 Insight Agent, a software-based agent that is used on assets across on-premises and cloud environments to centralize and monitor data on company's platform; Rapid7 Insight Network Sensor that analyzes raw end-to-end network traffic to increase visibility into user activity, pinpoint real threats, and investigations; Rapid7 Cloud Event Data Harvesting that offers visibility into changes made to cloud resources; and third-party integrations and ecosystem, as well as orchestration and automation solutions. It also offers various platforms, including Rapid7 managed threat complete consisting of managed detection response that delivers end-to-end threat detection and response; Rapid7 threat complete consisting of InsightIDR, a security information and event management, and extended detection and response solution; Incident Response Services to prepare and respond to potential breaches; Exposure Command, an exposure management to provide attack surface visibility; and Exposure Command Advanced to provide strong security for workloads leveraging real-time visibility, identity analysis, and automated remediation. In addition, the company provides Surface Command, a Cyber Asset Attack Service Management solution to detect and prioritize security issues from endpoint to cloud; Vector Command, a continuous red-teaming service that validates the external attack surface exposures and tests defenses; InsightCloudSec, a cloud risk and compliance management solution; InsightAppSec, a dynamic application security testing tool; and InsightVM, a vulnerability management solution that provides visibility across on-premise and remote endpoints for security. Further, it offers offloads day-to-day, advisory, and professional services. The company was incorporated in 2000 and is headquartered in Boston, Massachusetts.

Rapid7, Inc.

In a report released today, from Susquehanna maintained a Hold rating on Rapid7, with a price target of $15.00. In addition to Susquehanna, Rapid7 ...

Susquehanna Reaffirms Their Hold Rating on Rapid7 (RPD)

In a report released today, Fatima Boolani from Citi maintained a Hold rating on Rapid7, with a price target of $13.00. Boolani covers the Technolo...

Citi Keeps Their Hold Rating on Rapid7 (RPD)

Royalty Pharma PLC (($RPRX)) has held its Q2 earnings call. Read on for the main highlights of the call. Royalty Pharma’s latest earnings call stru...

Royalty Pharma lifts 2026 outlook amid strong cash flows

Companies in the NA sector have received a lot of coverage today as analysts weigh in on Rapid7 (RPD) and Ceribell, Inc. (CBLL). Rapid7 (RPD) In a ...

Analysts Offer Insights on NA Companies: Rapid7 (RPD) and Ceribell, Inc. (CBLL)

Jefferies analyst Joseph Gallo maintained a Hold rating on Rapid7 yesterday and set a price target of $12.00. The company’s shares closed yesterday...

Jefferies Keeps Their Hold Rating on Rapid7 (RPD)

Rapid7 Inc. (($RPD)) has held its Q2 earnings call. Read on for the main highlights of the call. Rapid7’s latest earnings call struck a tone of cau...

Rapid7 Earnings Call: Profitability Rises, Growth Tested

Rapid Nutrition ( ($FR:ALRPD) ) just unveiled an announcement. Rapid Nutrition is positioning itself at the nexus of artificial intelligence, perso...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	RPD	$13.29	-1.56%	1.43M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	RPD	$13.29	-1.6%	1.43M
3
4
5
6

RPD

Get Rapid7, Inc. Data in Excel

Get Rapid7, Inc. Data in Excel